IL18 and rheumatoid arthritis: Erdr1 suppresses IL-18 expression in synovial tissue and inhibits synovial fibroblast migration through inhibition of ERK1/2 phosphorylation, indicating that Erdr1 might be part of an effective therapeutic approach for RA based on its anti-inflammatory properties.